Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more
Arix Bioscience plc (LSE:ARIX) announced a series of senior management departures. CEO Joe Anderson has stepped down as CEO of the healthcare and life science investment company along with two undisclosed members of the senior team. Chairman Jonathan Peacock and Art Pappas, a non-executive director, will step down at the upcoming annual general meeting. Naseem Amin will become executive chairman; he was a non-executive director.
CDMO Emergent BioSolutions Inc. (NYSE:EBS) hired Nina DeLorenzo as SVP of global affairs. She was chief of staff, external affairs at Sanofi (Euronext:SAN; NASDAQ:SNY). Emergent has partnered with other companies to support COVID-19 vaccine manufacturing and received $14.5 million from BARDA for its convalescent plasma-derived COVID-19 therapy. ...